# DYANAVEL XR 20
> **NDA210526** · New Drug Application · Sponsor: TRIS PHARMA INC · Approved 2021-11-04
## Drug
- **FDA Application Number:** NDA210526
- **Application type:** New Drug Application
- **Brand name:** DYANAVEL XR 20
- **Generic name:** AMPHETAMINE
- **Active ingredients:** AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TRIS PHARMA INC
- **Manufacturer:** NextWave Pharmaceuticals, Inc
- **First approval:** 2021-11-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210526)
---
*AI Analytics · CC0 1.0*